CardioGenics Holdings (CGNH) Stock Statistics & Valuation Metrics

CardioGenics Holdings has a market cap or net worth of $120.00. The enterprise value is ―.

CardioGenics Holdings has 96,051,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

CardioGenics Holdings’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of CardioGenics Holdings is ―. CardioGenics Holdings’s PEG ratio is ―.

In the last 12 months, CardioGenics Holdings had revenue of ― and earned ― in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was -366.41K and capital expenditures 0.00, giving a free cash flow of -366.41K billion.

CardioGenics Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

CardioGenics Holdings upcoming earnings date is ―, ―.

CardioGenics Holdings as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, CardioGenics Holdings has paid ― in taxes.

CardioGenics Holdings EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

CardioGenics Holdings has $96.81K in cash and marketable securities with $378.50K in debt, giving a net cash position of -$281.69K billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for CardioGenics Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―